Mantle Cell Lymphoma | Tumor

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Managing Mantle Cell Lymphoma (MCL) after Relapsed on First Treatment

An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center

Keep Inspiring

Don’t let your disease define you

Patients With Previously Treated Multiple B-Cell Malignancies Respond Safely to Next-Generation BTK Inhibitor

April 6th 2021, 1:00pm

Article

Pirtobrutinib was safe and effective in treating patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma and Waldenstrom macroglobulinemia, some of whom developed intolerance or resistance to previous covalent BTK inhibitors.

Minimal Residual Disease Positivity After Treatment Could Lead to Worse Outcomes in MCL

February 16th 2021, 10:00pm

Article

A meta-analysis found that minimal residual disease positivity after a particular treatment for mantle cell lymphoma can predict worse survival benefit.

The Top 5 News and Updates in Mantle Cell Lymphoma That Patients May Have Missed in 2020

December 29th 2020, 7:00pm

Article

A roundup of some of the most read news and updates in mantle cell lymphoma in 2020 from CURE®.

Gazyva with Chemotherapy May Eliminate Disease in Bone Marrow Before Transplantation in Mantle Cell Lymphoma

November 16th 2020, 7:00pm

Article

This treatment, which included dexamethasone, high-dose cytarabine and cisplatin, was well tolerated in this patient population, although longer-term follow-up is needed to see if the benefit persists.

Closer to a Cure for Mantle Cell Lymphoma

September 25th 2020, 6:00pm

Article

Mantle Cell Lymphoma (MCL), as described in this issue of CURE®, has an interesting and inspiring story. It was one of the first cancers known to have a genetic abnormality-chromosomal translocation t(11;14).

Advances in the Treatment of Mantle Cell Lymphoma are Greatly Improving the Long-Term Outlook for Patients

September 22nd 2020, 6:00pm

Article

Exciting advances in treatment options for patients with mantle cell lymphoma are greatly improving the outlook for long-term remissions.

Cirmtuzumab Combinations Show Potential in Treatment of Mantle Cell Lymphoma

September 9th 2020, 9:00pm

Video

Dr. Lori A. Leslie discuses the potential of combination therapies with the emerging agent cirmtuzumab for patients with mantle cell lymphoma.

Bendamustine-Rituxan Combination Shows Promise in Frontline Treatment of Most Patients with Mantle Cell Lymphoma

September 2nd 2020, 1:00pm

Article

“Moving forward, (bendamustine and Rituxan) will likely become a common backbone for the incorporation of other cytotoxic or novel agents in an attempt to further improve outcomes while maintaining an effective, safe, and ideally outpatient regimen for MCL,” the authors wrote.

The Latest News and Updates in Mantle Cell Lymphoma

August 11th 2020, 1:00pm

Article

A roundup of the latest news and updates for patients with mantle cell lymphoma from CURE®.

Options for Patients with Mantle Cell Lymphoma Are 'Exploding', Expert Says

August 10th 2020, 7:00pm

Video

“It really is an exciting time for patients with lymphoma, because the options are just really exploding at a very encouraging rate,” said Dr. Lori A. Leslie.